| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 15,709 | 16,661 | 17,576 | 22,728 | | Cost of Revenue |
-
| (1,710) | 1,710 | 1,646 | | | Gross Profit | 15,709 | 18,371 | 15,866 | 21,082 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,218 | 8,913 | 4,915 | 5,475 | | Non Recurring | 1,420 | (666) | (674) | 49,540 | | Others | 4,664 | 4,622 | 4,779 | 5,010 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,951 | 5,502 | 6,846 | (38,943) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,542 | 6 | 4 | 21 | | Earnings Before Interest And Taxes | 4,949 | 5,508 | 6,850 | (38,922) | | Interest Expense | 992 | 1,050 | 1,302 | 2,808 | | Income Before Tax | 3,957 | 4,458 | 5,548 | (41,730) | | Income Tax Expense | 763 | 1,125 | 1,593 | 2,665 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,194 | 3,333 | 3,955 | (44,395) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,194 | 3,333 | 3,955 | (44,395) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,194 | $3,333 | $3,955 | ($44,395) |
|
0.51% Nasdaq 
0.05 (0.55%) 
Income Statement
